drugset / Trial / NCT03813277

Safety, Tolerability and Efficacy of DEXDOR in Pediatric Patients in ICU

NCT03813277 ↗

Phase 4 Completed 60 enrolled Orion Corporation, Orion Pharma
NaSingle-groupOpen-labelTreatment

Summary

Open clinical trial to evaluate safety, tolerability, and efficacy of Dexdor for sedation in paediatric patients in intensive care settings. Multi-centre trial in Russia for marketing registration of Dexdor

Timeline

Start
2017-03-21
Primary completion
2018-05-21
Completion
2018-05-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 100 ug/ml Other

Indications

No indication recorded.